Biostrategies LC

Biostrategies LC is a small business in Jonesboro, AR registered on SAM.gov to bid on federal contracts. It has won 12 small business R&D awards worth $14.3 million through the SBIR and STTR programs since 2016, according to SBIR.gov.

UEI
PE6MEQZRFW63
CAGE code
4BJ87
SAM.gov registration
Active

Registration details

Legal business nameBiostrategies LC
Unique Entity ID (UEI)PE6MEQZRFW63
CAGE code4BJ87
LocationJonesboro, AR
SAM.gov registrationActive through Feb 27, 2027
Business started2007
Primary NAICS code541714: Research and Development in Biotechnology (except Nanobiotechnology)

Certifications and business types

  • Veteran-owned (self-reported in SAM.gov)

SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.

SBIR and STTR awards

Biostrategies LC has won 12 small business R&D awards worth $14.3 million through the SBIR and STTR programs since 2016, 5 of them Phase II. Funded by NIH.

AwardedAgencyProjectAmount
Sep 15, 2025NIHSBIR Phase II Treatment of GM1 gangliosidosis CNS manifestations by AAV systemic expression of lectin-enhanced…$1.5 million
Sep 20, 2023NIHSBIR Phase I Morquio A therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat…$295,923
Sep 15, 2023NIHSBIR Phase II Gene Therapy that Systemically Produces Brain-penetrating Replacement Enzyme for MPS IIIA…$3 million
Jul 15, 2022NIHSBIR Phase I Krabbe disease therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat…$390,497
Aug 15, 2020NIHSBIR Phase I Treatment of muscular symptoms in Pompe rare disease via lectin assisted ERT delivery$250,000
Apr 9, 2020NIHSBIR Phase II Enzyme Replacement Therapeutics for Rare Childhood Genetic Diseases: An ERT Delivery System that…$2 million
Sep 1, 2019NIHSBIR Phase I Lectin-mediated ERT Delivered to Cardiac Tissue in Fabry Disease$293,232
Jul 1, 2018NIHSBIR Phase I MPS I Skeletal Disease Therapy with Novel Lectin-delivered Replacement Enzyme$225,000

Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.

Federal contract history

USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.

NAICS codes Biostrategies LC is small under

On its SAM.gov registration, Biostrategies LC meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.

  • 541714 Research and Development in Biotechnology (except Nanobiotechnology)

Open contracts in Biostrategies LC's NAICS codes

36 open federal opportunities on SAM.gov use a NAICS code Biostrategies LC is small under. These are due soonest.

Get matches like these by email, free →

Similar small businesses

Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with Arkansas:

Frequently asked questions

What is Biostrategies LC's CAGE code?

Biostrategies LC's CAGE code is 4BJ87. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.

What is Biostrategies LC's UEI?

Biostrategies LC's Unique Entity ID (UEI) is PE6MEQZRFW63. SAM.gov assigns the UEI, and it identifies the business across the federal government.

Is Biostrategies LC's SAM.gov registration active?

Yes, as of the latest SAM.gov public data, Biostrategies LC's registration is active through Feb 27, 2027. Registrations are renewed every year.

Is Biostrategies LC a small business?

Biostrategies LC is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.

Keep going

Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.